A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer

Daniele Generali*, Sergio Venturini, Carla Rognoni, Oriana Ciani, Lajos Pusztai, Sherene Loi, Guy Jerusalem, Alberto Bottini, Rosanna Tarricone

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Fingerprint

Entra nei temi di ricerca di 'A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer'. Insieme formano una fingerprint unica.

Pharmacology, Toxicology and Pharmaceutical Science